Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVADEL PHARMA INC | 3,568,372 | reported | 31 Dec 2009 | tx 23+5,178,372 |
| INKINE PHARMACEUTICAL CO INC | 22,500 | reported | 02 Jun 2003 | tx 5+122,500 |
| EAGLE PHARMACEUTICALS, INC. | 16,253 | reported | 07 Mar 2023 | tx 30+143,637−34,054 |
| AXONYX INC | 10,000 | reported | 19 Jun 2008 | tx 7+194,158 |
| CIMA LABS INC | 0 | reported | 12 Aug 2004 | tx 14+25,000−104,155 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Mar 2023 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 16,253 | 0.00 USD | deriv |
| 28 Feb 2022 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 11,200 | 0.00 USD | deriv |
| 08 Apr 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 8.78 USD | |
| 08 Apr 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 8.78 USD | |
| 08 Apr 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 4.42 USD | |
| 08 Apr 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.00 USD | deriv |
| 08 Apr 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.00 USD | deriv |
| 08 Apr 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.00 USD | deriv |
| 28 Feb 2020 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 8.78 USD | |
| 28 Feb 2020 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.00 USD | deriv |
| 02 Feb 2021 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 13,500 | 0.00 USD | deriv |
| 05 Jan 2020 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 04 Mar 2019 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 4.04 USD | |
| 04 Mar 2019 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.00 USD | deriv |
| 23 Jan 2019 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 07 Jan 2018 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 18 Dec 2017 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.90 USD | |
| 18 Dec 2017 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2,340 | 0.00 USD | deriv |
| 04 Jan 2017 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 03 Apr 2014 | PURCHASE | EAGLE PHARMACEUTICALS, INC. | 3,950 | 12.79 USD | first after silence |
| 12 Dec 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 1,300 | 75.07 USD | |
| 13 Dec 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 8,700 | 75.00 USD | |
| 04 Jan 2016 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 21 Apr 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 13 Mar 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 5,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 03 Apr 2014.